ScienceDex / Researcher record
Ian David Aronson
- Ndri-Usa, Inc. (no department on record)
From the FY2024 NIH awards this investigator leads as contact PI. The department is the award's.
- R01 Holder
- Early Career
NIH Funding · FY2024
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2024 | $1,265,226 | 2 | #11,182 |
| 2026 | $912,137 | 1 | #20,836 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY2024 · selected2 records
- FY20261 record
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 10651315Search this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
FY2024 award records by amount
NIH award records listing Ian David Aronson as a PI. Multi-PI records show the full award amount for context.
- 1R61DA059035-01A1R61Contact PITogether Against Overdose: community developed technology to encourage drug checking, distribution of harm reduction supplies, and linkage to services$803.6Kaward amount
- 7R01DA054990-04R01Contact PICommunity Developed Technology-Based Messaging to Increase SARS-CoV-2 Vaccine Uptake Among People Who Inject Drugs$461.7Kaward amount
Award organization
Organizations that administered FY2024 awards listing Ian David Aronson as a PI.
FY2024 award administered by Ndri-Usa, Inc. (NY).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardNdri-Usa, Inc.
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024R01 Grant Holder
- 2026$2M Cumulative Funding